Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · operational-macro

Trinity Biotech to seek Nasdaq listing hearing

28 August 2026 · By · Wire by Fusion42

Published

28 August 2026

Topic

operational-macro

◆ Sectors

Biotech

◆ Geography

Ireland

◆ Source

Read at stocktitan.net →

◆ Verified

Fusion42 · 28 August 2026 · Fusion42 review

Trinity Biotech announced ongoing progress in its diagnostics business transformation, including commercial expansion in Europe, rollout of upgraded HbA1c column technology, operational shifts to outsourced manufacturing for HIV tests, and updates on its Nasdaq listing plans.

This Wire brief sits within Fusion42's coverage of Biotech.

◆ ◆ The Wire takeaway

Your biotech firm's public market access just advanced in Ireland with Trinity Biotech's Nasdaq hearing update. Prepare for shifts in capital availability and competitive positioning as foreign exchange and reporting standards await your attention.

◆ Coverage

1 source · 28 Aug 2026

◆ Related on Wire

◆ Topics

Biotechnasdaq-listingdiagnosticsmanufacturing-transformationpatentscommercial-expansion